Evicenter
MarkdownMedical informationP&T meetings
Claseprubart (DNTH103)

Chronic inflammatory demyelinating polyneuropathy

Launch
Not announced
Last updated
143 sources

Product information and disease descriptionProduct description

Phase of product development

8 evidence topics · 9 sources

Launch

No evidence found.

Orphan drug, fast track, or breakthrough therapy designation for CIDP

No evidence found.